<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>26277207</identifier>
<setSpec>1578-1852</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>González-Torralba, Ana</dc:author>
<dc:author>García-Esteban, Coral</dc:author>
<dc:author>Alós, Juan-Ignacio</dc:author>
<dc:description xml:lang="en">Infectious gastroenteritis remains a public health problem. The most severe cases are of bacterial origin. In Spain, Campylobacter and Salmonella are the most prevalent bacterial genus, while Yersinia and Shigella are much less frequent. Most cases are usually self-limiting and antibiotic therapy is not generally indicated, unless patients have risk factors for severe infection and shigellosis. Ciprofloxacin, third generation cephalosporins, azithromycin, ampicillin, cotrimoxazole and doxycycline are the most recommended drugs. The susceptibility pattern of the different bacteria determines the choice of the most appropriate treatment. The aim of this review is to analyse the current situation, developments, and evolution of resistance and multidrug resistance in these 4 enteric pathogens.</dc:description>
<dc:type>Journal Article</dc:type>
<dc:language>es</dc:language>
<dc:subject>Enteropatógenos</dc:subject>
<dc:subject>Antimicrobianos</dc:subject>
<dc:subject>Antimicrobials</dc:subject>
<dc:subject>Antibiotic resistance</dc:subject>
<dc:subject>Enteropathogens</dc:subject>
<dc:subject>Resistencia antibiótica</dc:subject>
<dc:date>2018 Jan </dc:date>
<dc:title xml:lang="es">Enteropatógenos y antibióticos.</dc:title>
<dc:title xml:lang="en">Enteropathogens and antibiotics.</dc:title>
<dc:publisher>Enfermedades infecciosas y microbiologia clinica</dc:publisher>
</metadata>
</record>
</pubmed-document>
